Search

Your search keyword '"Dysferlin"' showing total 1,831 results

Search Constraints

Start Over You searched for: Descriptor "Dysferlin" Remove constraint Descriptor: "Dysferlin"
1,831 results on '"Dysferlin"'

Search Results

51. CELLULAR AND MOLECULAR MECHANISMS OF MUSCLE REGENERATION

52. Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in Limb Girdle Muscular Dystrophy Type R2

53. A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.

54. Structural and ultrastructural changes in the skeletal muscles of dysferlin-deficient mice during postnatal ontogenesis.

55. A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy

56. Muscular Dystrophies

60. Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.

61. Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes

62. Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia

63. Analysis of Dysferlin Direct Interactions with Putative Repair Proteins Links Apoptotic Signaling to Ca2+ Elevation via PDCD6 and FKBP8

64. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy.

65. Caracterização da força e da função muscular nas disferlinopatias em amostra brasileira.

66. The Dysferlin Transcript Containing the Alternative Exon 40a is Essential for Myocyte Functions

68. Integrated Genome and Transcriptome Sequencing to Solve a Neuromuscular Puzzle: Miyoshi Muscular Dystrophy and Early Onset Primary Dystonia in Siblings of the Same Family

69. Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions

70. Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions.

71. Integrated Genome and Transcriptome Sequencing to Solve a Neuromuscular Puzzle: Miyoshi Muscular Dystrophy and Early Onset Primary Dystonia in Siblings of the Same Family.

72. Deep phenotyping of an international series of patients with late‐onset dysferlinopathy.

73. A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B

74. Null variants in DYSF result in earlier symptom onset.

75. Abnormal Expression of Dysferlin in Blood Monocytes Supports Primary Dysferlinopathy in Patients Confirmed by Genetic Analyses

76. Abnormal Expression of Dysferlin in Blood Monocytes Supports Primary Dysferlinopathy in Patients Confirmed by Genetic Analyses.

77. Sarcolemma wounding activates dynamin‐dependent endocytosis in striated muscle.

78. On the role of dysferlin in striated muscle: membrane repair, t-tubules and Ca 2+ handling.

79. Nanodysferlins support membrane repair and binding to TRIM72/MG53 but do not localize to t-tubules or stabilize Ca 2+ signaling.

80. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B

81. Compound heterozygous DYSF variants causing limb‐girdle muscular dystrophy type 2B in a Chinese family.

82. The effects of concentric and eccentric training in murine models of dysferlin-associated muscular dystrophy.

83. The genetic profile of dysferlinopathy in a cohort of 209 cases: Genotype–phenotype relationship and a hotspot on the inner DysF domain.

84. Dysferlin-deficient myotubes show tethering of different membrane compartments characterized by TMEM16E and DHPRα.

85. Dysferlin links excitation-contraction coupling to structure and maintenance of the cardiac transverse-axial tubule system.

86. Impaired muscle spindle function in murine models of muscular dystrophy.

87. Increased erythrocyte osmotic fragility in hypothyroidism.

88. Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells.

89. Age‐related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age.

90. DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B

91. Cardiomyocyte damage control in heart failure and the role of the sarcolemma.

92. Unexpected extra exon skipping in the DYSF gene during restoring the reading frame by CRISPR/Cas9.

93. Dysferlinopathies: Clinical and genetic variability

94. Duchenne muscular dystrophy: A immunohistochemical profile and deletion pattern in dystrophin gene in North Indian population

95. Thermoneutral Housing and a Western Diet Combination Exacerbates <scp>Dysferlin‐Deficient</scp> Muscular Dystrophy

96. High Prevalence of a c.5979dupA Variant in the Dysferlin Gene (DYSF) in Individuals from a Semiarid Region of Brazil.

98. Faster regeneration associated to high expression of Fam65b and Hdac6 in dysferlin-deficient mouse.

99. Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests.

100. Abnormal Membrane Localization of α2 Isoform of Na,K-ATPase in m. soleus of Dysferlin-Deficient Mice.

Catalog

Books, media, physical & digital resources